Recommended literature
- Lazou A, et.al.. Chronic inflammatory diseases, myocardial function and cardioprotection. Br J Pharmacol. https://doi.org/10.1111/bph.14975
- Bitoun S, et.al; ABIRISK Consortium. Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies. doi: 10.1001/jamanetworkopen.2023.23098.
- Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response – PubMed (nih.gov)
- Antidrug Antibody, Therapeutic Drug Monitoring: Status Update and Future Directions in Spondyloarthritis https://doi.org/10.1002/art.42931
- Long-term follow-up of anti-infliximab antibodies in radiographic axial spondyloarthritis patients: a marker of drug survival and tapering https://doi.org/10.1002/art.42923
- Relationship Between Adalimumab Concentrations, Antidrug Antibodies, and Disease Activity in Rheumatoid Arthritis: A Cross-Sectional Observational Study https://doi.org/10.3899/jrheum.2023-0706
